Background: The prevalence of kidney disease (KD) due to inherited genetic conditions in Ireland is unknown. The aim of this study was to characterise an adult kidney disease population in Ireland and to identify familial clusters of kidney disease within the population. Methods: This was a multicenter cross-sectional study of patients with kidney disease in the Republic of Ireland, from January 2014 to September 2014, recruiting from dialysis units and out-patient renal departments. A survey was performed by collecting data on etiology of kidney disease and whether a family history of kidney disease exists. Medical records were cross-referenced to confirm the etiology of kidney disease. Results: A total of 1,840 patients were recruited with a mean age of 55.9 years (range 17-94.5) and a male predominance (n = 1,095; 59.5%). A positive family history was reported by 629 participants (34.2%). Excluding polycystic kidney disease (n = 134, 7.3%), a positive family history was reported by 495 participants (26.9%). Kidney disease due to an unknown etiology was the commonest etiology in the non-polycystic kidney disease group with a positive family history (10.6%, n = 67). Kidney diseases that are not classically associated with familial inheritance including tubulo-interstitial kidney disease, congenital abnormalities of the kidney and urinary tract and glomerulonephritis demonstrated familial clustering. Conclusion: In an Irish non-polycystic kidney disease population, 26.9% reports a positive family history. The commonest etiology of kidney disease in the positive family history cohort, excluding autosomal dominant polycystic kidney disease, was kidney disease due to unknown etiology. Examining families with kidney disease provides an opportunity to better understand disease pathogenesis and potentially identify genetic predispositions to kidney disease.

Keywords:
Genetic factors, Kidney disease, Family history, Hereditary nephropathy
1.
Central Statistics Office: Population and Migration Estimates: CSO Statistical Release. Dublin, Government Publications Office, 2014.
2.
National Renal Office: Epidemiology of ESKD in Adults in Ireland: Report from 2013 Census. Ireland, Health Service Executive of Ireland, 2013, p 9.
3.
Barzilay J, Warram JH, Bak M, Laffel LM, Canessa M, Krolewski AS: Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int 1992;41:723-730.
4.
Ismail N, Becker B, Strzelczyk P, Ritz E: Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int 1999;55:1-28.
5.
Stengel B, Billon S, Van Dijk PC, Jager KJ, Dekker FW, Simpson K, Briggs JD: Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 2003;18:1824-1833.
6.
Lei HH, Perneger TV, Klag MJ, Whelton PK, Coresh J: Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol 1998;9:1270-1276.
7.
Hildebrandt F: Genetic kidney diseases. Lancet 2010;375:1287-1295.
8.
Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A, Kimmel PL, Sperati CJ, Orr-Urtreger A, Ben-Shachar S, Waugh DA, McGinn S, Bleyer AJ Jr, Hodanova K, Vylet'al P, Zivna M, Hart TC, Hart PS: Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Clin J Am Soc Nephrol 2014;9:527-535.
9.
Stack AG, Casserly LF, Cronin CJ, Chernenko T, Cullen W, Hannigan A, Saran R, Johnson H, Browne G, Ferguson JP: Prevalence and variation of chronic kidney disease in the Irish health system: initial findings from the national kidney disease surveillance programme. BMC Nephrol 2014;15:185.
10.
Browne GM, Eustace JA, Fitzgerald AP, Lutomski JE, Perry IJ: Prevalence of diminished kidney function in a representative sample of middle and older age adults in the Irish population. BMC Nephrol 2012;13:144.
11.
Glynn LG, Anderson J, Reddan D, Murphy AW: Chronic kidney disease in general practice: prevalence, diagnosis, and standards of care. Ir Med J 2009;102:285-288.
12.
Central Statistics Office: Population and Migration Estimates - April 2014. Central Statistics Office, 2015.
13.
Venkat-Raman G, Tomson CR, Gao Y, Cornet R, Stengel B, Gronhagen-Riska C, Reid C, Jacquelinet C, Schaeffner E, Boeschoten E, Casino F, Collart F, De Meester J, Zurriaga O, Kramar R, Jager KJ, Simpson K; ERA-EDTA Registry: New primary renal diagnosis codes for the ERA-EDTA. Nephrol Dial Transplant 2012;27:4414-4419.
14.
Zinner SH, Levy PS, Kass EH: Familial aggregation of blood pressure in childhood. N Engl J Med 1971;284:401-404.
15.
Satko SG, Freedman BI: The importance of family history on the development of renal disease. Curr Opin Nephrol Hypertens 2004;13:337-341.
16.
Wei X, Li Z, Chen W, Mao H, Li Z, Dong X, Tan J, Ling L, Chen A, Guo N, Yu X: Prevalence and risk factors of chronic kidney disease in first-degree relatives of chronic kidney disease patients in southern china. Nephrology (Carlton) 2012;17:123-130.
17.
Freedman BI, Soucie JM, McClellan WM: Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol 1997;8:1942-1945.
18.
Skrunes R, Svarstad E, Reisaeter AV, Vikse BE: Familial clustering of ESRD in the Norwegian population. Clin J Am Soc Nephrol 2014;9:1692-1700.
19.
Ekici AB, Hackenbeck T, Moriniere V, Pannes A, Buettner M, Uebe S, Janka R, Wiesener A, Hermann I, Grupp S, Hornberger M, Huber TB, Isbel N, Mangos G, McGinn S, Soreth-Rieke D, Beck BB, Uder M, Amann K, Antignac C, Reis A, Eckardt KU, Wiesener MS: Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin. Kidney Int 2014;86:589-599.
20.
Malik TH, Lavin PJ, Goicoechea de Jorge E, Vernon KA, Rose KL, Patel MP, de Leeuw M, Neary JJ, Conlon PJ, Winn MP, Pickering MC: A hybrid CFHR3-1 gene causes familial C3 glomerulopathy. J Am Soc Nephrol 2012;23:1155-1160.
21.
Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS, Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Eng CM: Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013;369:1502-1511.
22.
Gooneratne IK, Ranaweera AK, Liyanarachchi NP, Gunawardane N, Lanerolle RD: Epidemiology of chronic kidney disease in a Sri Lankan population. Int J Diabetes Dev Ctries 2008;28:60-64.
23.
Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO: Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst 2006;98:61-68.
24.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW: Chronic kidney disease: global dimension and perspectives. Lancet 2013;382:260-272.
25.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047.
26.
Ferguson R, Grim CE, Opgenorth TJ: A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol 1988;41:1189-1196.
27.
Freedman BI, Spray BJ, Tuttle AB, Buckalew VM Jr: The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 1993;21:387-393.
28.
Freedman BI, Bowden DW: The role of genetic factors in the development of end-stage renal disease. Curr Opin Nephrol Hypertens 1995;4:230-234.
29.
Freedman BI: Susceptibility genes for hypertension and renal failure. J Am Soc Nephrol 2003;14(7 suppl 2):S192-S194.
30.
Whittle JC, Whelton PK, Seidler AJ, Klag MJ: Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med 1991;151:1359-1364.
31.
McClellan W, Tuttle E, Issa A: Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 1988;12:285-290.
32.
Byrne C, Nedelman J, Luke RG: Race, socioeconomic status, and the development of end-stage renal disease. Am J Kidney Dis 1994;23:16-22.
33.
Bostrom MA, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW: Association of polymorphisms in the klotho gene with severity of non-diabetic ESRD in African Americans. Nephrol Dial Transplant 2010;25:3348-3355.
34.
Genovese G, Tonna SJ, Knob AU, Appel GB, Katz A, Bernhardy AJ, Needham AW, Lazarus R, Pollak MR: A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 2010;78:698-704.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.